Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

被引：0
|
作者：
Zhong, Xinxin [1 ]
Lin, Ao [2 ]
Luo, Jian [1 ]
Li, Yeqin [1 ]
Chen, Jinlan [1 ]
Ning, Chao [1 ]
Cao, Fu [1 ,3 ]
机构：
[1] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, Yulin 537000, Guangxi, Peoples R China
[2] Red Cross Hosp Yulin City, Dept Cardiothorac Surg, Yulin 537000, Guangxi, Peoples R China
[3] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, 1 Jinwang Rd, Yulin 537000, Guangxi, Peoples R China
来源：
POSTGRADUATE MEDICAL JOURNAL | 2024年 / 100卷 / 1184期
关键词：
antituberculosis drugs; multidrug-resistance; mycobacterium; chemotherapy; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; IN-VITRO; MDR-TB; BEDAQUILINE; REGIMENS; PRETOMANID; DISCOVERY; DELAMANID; EFFICACY;
D O I：
10.1093/postmj/qgad140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
引用
收藏
页码：366 / 372
页数：7
相关论文
共 50 条
  • [31] New treatment options for multidrug-resistant tuberculosis
    Field, Stephen K.
    Fisher, Dina
    Jarand, Julie M.
    Cowie, Robert L.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (05) : 255 - 268
  • [32] Common errors in multidrug-resistant tuberculosis management
    Monedero, Ignacio
    Caminero, Jose A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (01) : 15 - 23
  • [33] Multidrug-resistant tuberculosis: current epidemiology, therapeutic regimens, new drugs
    Gomez-Ayerbe, Cristina
    Jesus Vivancos, Maria
    Moreno, Santiago
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 : 35 - 38
  • [34] Characterization of clinical isolates of Mycobacterium tuberculosis resistant to drugs and detection of RpoB mutation in multidrug-resistant tuberculosis in the Philippines
    Agdamag, DMD
    Kageyama, S
    Solante, R
    Espantaleon, AS
    Sangco, JCE
    Suzuki, Y
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (11) : 1104 - 1108
  • [35] Multidrug-resistant Tuberculosis
    Lynch, John B.
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (04) : 553 - +
  • [36] Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience
    Tiberi, Simon
    D'Ambrosio, Lia
    De Lorenzo, Saverio
    Viggiani, Pietro
    Centis, Rosella
    Sotgiu, Giovanni
    Alffenaar, Jan Wilem C.
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) : 333 - 336
  • [37] Lessons from a randomised clinical trial for multidrug-resistant tuberculosis
    Padayatchi, N.
    Mac Kenzie, W. R.
    Hirsch-Moverman, Y.
    Peng, P-J.
    Villarino, E.
    Saukkonen, J.
    Heilig, C. M.
    Weiner, M.
    El-Sadr, W. M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (12) : 1582 - 1587
  • [38] Multidrug-resistant tuberculosis
    Wulandari, Dika Apriliana
    Hartati, Yeni Wahyuni
    Ibrahim, Abdullahi Umar
    Pitaloka, Dian Ayu Eka
    Irkham
    CLINICA CHIMICA ACTA, 2024, 559
  • [39] Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
    Schecter, G. F.
    Scott, C.
    True, L.
    Raftery, A.
    Flood, J.
    Mase, S.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (01) : 49 - 55
  • [40] Linezolid for the treatment of multidrug-resistant tuberculosis
    Fortún, J
    Martín-Dávila, P
    Navas, E
    Pérez-Elías, MJ
    Cobo, J
    Tato, M
    De la Pedrosa, EGG
    Gómez-Mampaso, E
    Moreno, S
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) : 180 - 185
12345